The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

India's vaccination platform readied to handle 10 mln shots daily- official

Fri, 29th Jan 2021 12:40

* India aims to have vaccinated 300 million by August

* It has so far inoculated about 3 million healthcare
workers

* Inoculation campaign suffered some early software glitches

* CoWIN platform to be integrated with contact-tracing app

By Devjyot Ghoshal and Krishna N. Das

NEW DELHI, Jan 29 (Reuters) - The digital platform anchoring
India's massive COVID-19 vaccination drive will be able to
handle up to 10 million shots daily to meet the country's target
of covering 300 million people by July-August, a government
official told Reuters.

India, which has the world's second-highest number of
coronavirus cases, is relying on CoWIN to link beneficiaries
with vaccines in what the government touts as the biggest
inoculation campaign anywhere.

The world's most populous country after China has vaccinated
around three million healthcare workers in the first two weeks
of the campaign, at a rate of just over 200,000 a day on
average, but this will have to be raised many times over if
India is to meet its summer coverage target.

Though initial glitches in the software slowed the
immunisation programme, which began on Jan. 16 with frontline
workers, the government says modifications have been made to
ensure there is no such repeat.

"Big numbers won't be a problem for us," R.S. Sharma, who
chairs a government group overseeing CoWIN, said in a Zoom
interview. "We will be able to do 10 million vaccinations per
day."

Sharma said CoWIN would be integrated into government
contact-tracing app "Aarogya Setu", or Health Bridge, which has
been downloaded by around 150 million people.

'NOT A FAD'

It is using a vaccine developed at home by Bharat Biotech
and the Indian Council of Medical Research, and another licensed
from Oxford University and AstraZeneca.

In the coming months, India is expected to approve two more
vaccines, Russia's Sputnik V and Cadila Healthcare's
ZyCov-D.

Sharma said individuals would be able to choose vaccination
slots and get QR-coded certificates once they have taken their
shots through CoWIN, allowing them to carry a proof that can be
used for, say, air or foreign travel.

"It's not a fad," he said, "It cannot be done without
technology."

India, the world's biggest vaccine maker, is also gifting or
selling shots to more than a dozen countries, and Sharma said
there had already been some international interest in using the
CoWIN platform, including from South Africa.

At home, Sharma said CoWIN would use online and offline
systems to register beneficiaries, including through telephone
help lines and walk-in centres.

"There will be millions of registrations every day and the
system should be able to handle it effortlessly," he said.

Discussions were still underway on how to inoculate such
large numbers of people, including possibly using a combination
of government and private health facilities, said Sharma, who is
also part of a national expert group on vaccine administration.

With 10.7 million confirmed COVID-19 infections, India, with
a total population of nearly 1.4 billion, trails only the United
States' tally.

It reported 18,855 new cases in the past 24 hours, the
highest in three weeks, while deaths rose by 163 to a total of
154,000.
(Reporting by Devjyot Ghoshal and Krishna N. Das
Editing by Gareth Jones)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.